Actually, I'm certain that at a long ago presentation we were told peer reviews would likely happen sometime this year.
It sounded like they do take ages, so I haven't been waiting on those. The FDA feedback is foremost on my mind, and I'm going to be very surprised if it's not good news for us. One area PR and the team has excelled in is the scientific research.
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Appoints Business Development Consultant
Ann: PAR Appoints Business Development Consultant, page-312
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
0.010(4.35%) |
Mkt cap ! $85.70M |
Open | High | Low | Value | Volume |
24.0¢ | 25.0¢ | 24.0¢ | $146.6K | 603.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 46898 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 4785 | 0.240 |
2 | 52553 | 0.235 |
11 | 242789 | 0.230 |
6 | 90050 | 0.225 |
11 | 192340 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 44200 | 3 |
0.250 | 44198 | 3 |
0.260 | 20555 | 3 |
0.270 | 13000 | 2 |
0.275 | 10000 | 1 |
Last trade - 11.16am 20/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |